The goal of this research is to use the cyclotron-produced, short-lived radionuclide nitrogen-13 to study the in vivo metabolism of labeled L-amino acids and ammonia in murine tumors which are sensitive or resistant to glutaminase or asparaginase therapy. The metabolites of these N-13 labeled radiopharmaceuticals in blood and tumor homogenates will be determined using reverse phase and ion exchange chromatographic analyses. Tissue distribution studies using N-13 ammonia and L-(amide-N-13) glutamine have been performed in control and glutaminase 7A treated Sarcoma-180 (glutaminase sensitive) and Ridgeway Osteogenic Sarcoma (glutaminase resistant) mice. There do not appear to be any significant differences in the tissue distributions of N-13 ammonia or glutamine between the glutaminase-treated and control mice. Metabolic fate studies have been performed on tumor and blood homogenates 1, 5, and 10 min after either N-13 ammonia or N-13 glutamine administration in treated glutaminase-sensitive and -resistant tumor-bearing mice. The metabolic fate of the N-13 label after administration of either agent is primarily N-13 urea with the concentration increasing with time with smaller amounts in the acidic metabolites and in acidic amino acids. No labeled urea (only an unknown co-eluant) was formed during in vitro studies in which S-180 tumor slices were incubated with N-13 ammonia, suggesting that the N-13 urea formed in the tumor in the in vivo studies was not due to de novo synthesis in the tumor. Metabolic fate studies performed to date on Sarcoma-180 tumor and blood homogenates in glutaminase-treated animals after N-13 ammonia injection do not appear to be significantly different from untreated animals. (B)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R23)
Project #
5R23CA033732-03
Application #
3446462
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1983-02-01
Project End
1986-01-31
Budget Start
1985-02-01
Budget End
1986-01-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Cooper, A J; Nieves, E; Rosenspire, K C et al. (1988) Short-term metabolic fate of 13N-labeled glutamate, alanine, and glutamine(amide) in rat liver. J Biol Chem 263:12268-73
Nieves, E; Rosenspire, K C; Filc-DeRicco, S et al. (1986) High-performance liquid chromatographic on-line flow-through radioactivity detector system for analyzing amino acids and metabolites labeled with nitrogen-13. J Chromatogr 383:325-37
Rosenspire, K C; Gelbard, A S; Cooper, A J et al. (1985) [13N]Ammonia and L-[amide-13N]glutamine metabolism in glutaminase-sensitive and glutaminase-resistant murine tumors. Biochim Biophys Acta 843:37-48
Gelbard, A S; Kaseman, D S; Rosenspire, K C et al. (1985) Enzymatic syntheses of carbamyl phosphate, L-citrulline, and N-carbamyl L-aspartate labeled with either 13N or 11C. Int J Nucl Med Biol 12:235-42